MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 106 filers reported holding MYOVANT SCIENCES LTD in Q3 2021. The put-call ratio across all filers is 3.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $4,469,000 | -30.7% | 335,527 | -19.0% | 0.01% | -20.0% |
| Q4 2021 | $6,453,000 | -45.5% | 414,433 | -21.5% | 0.02% | -46.4% |
| Q3 2021 | $11,851,000 | -2.5% | 528,111 | -1.1% | 0.03% | -3.4% |
| Q2 2021 | $12,160,000 | -68.0% | 534,019 | -71.1% | 0.03% | -70.1% |
| Q1 2021 | $37,980,000 | -26.1% | 1,845,479 | -0.8% | 0.10% | -28.7% |
| Q4 2020 | $51,387,000 | +100.4% | 1,860,497 | +1.9% | 0.14% | +65.9% |
| Q3 2020 | $25,641,000 | -9.6% | 1,824,962 | +32.6% | 0.08% | -17.2% |
| Q2 2020 | $28,378,000 | +98.2% | 1,376,223 | -27.4% | 0.10% | +57.1% |
| Q1 2020 | $14,317,000 | -50.5% | 1,896,360 | +1.8% | 0.06% | -34.4% |
| Q4 2019 | $28,920,000 | +459.3% | 1,863,400 | +87.4% | 0.10% | +433.3% |
| Q3 2019 | $5,171,000 | -71.1% | 994,507 | -49.6% | 0.02% | -69.0% |
| Q2 2019 | $17,869,000 | -61.9% | 1,974,460 | +0.4% | 0.06% | -62.8% |
| Q1 2019 | $46,922,000 | +49.4% | 1,965,705 | +2.7% | 0.16% | +35.7% |
| Q4 2018 | $31,401,000 | -37.6% | 1,913,548 | +0.9% | 0.12% | -17.9% |
| Q3 2018 | $50,362,000 | +89.5% | 1,896,880 | +63.2% | 0.14% | +79.5% |
| Q2 2018 | $26,575,000 | +751.8% | 1,162,010 | +692.1% | 0.08% | +766.7% |
| Q1 2018 | $3,120,000 | – | 146,706 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| VitalStone Financial, LLC | 15 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $27 | 0.00% |